{"id":"42d2c3c8-ee9c-41bb-98e7-598ab19d50b5","arxiv_id":"2411.16264","paper_version":1,"verdict":"CONDITIONAL","confidence":"MODERATE","novelty_score":3.0,"correctness_risk":"medium","formal_verification":"none","parameter_count":4,"one_line_summary":"In a preliminary re-analysis of the HNSCC-MDA dataset, post-radiotherapy increases in an L3 adiposity index were associated with higher recurrence and mortality, and the muscle-loss plus fat-gain group had the worst outcomes.","lead":"This paper analyzes a public cancer imaging dataset to test whether changes in muscle and fat after radiotherapy predict recurrence of head and neck cancer. It reports that patients who gain fat after treatment have higher recurrence and death rates, especially when they also lose muscle.","discovery_kind":"extension","skeptic_critique":{"model":"deepseek-v4-flash","headline":"The reported association between post-RT adiposity gain and recurrence/mortality is not yet robust: the models in Sections 3.1 and 3.2 omit baseline body composition and key confounders, so the estimated effect of the change may reflect baseline nutritional risk rather than the change itself.","rationale":"Read in good faith, this is a clearly labeled preliminary analysis built on a public dataset with reported coefficients and directionally plausible results. I find no internal mathematical inconsistency in the numbers as presented, and I credit the authors for explicitly calling the work preliminary and for listing limitations. The reader's conditional verdict is appropriate. My stress-test identified a slightly different load-bearing point than the reader's weakest_assumption: rather than (or in addition to) missing sample-size documentation, the key scientific vulnerability is that the central association is estimated from models that omit baseline body composition and major confounders. Because the HNSCC-MDA cohort is public, this is checkable; the check proposed above would settle whether the claim survives. Since this concern is exactly the kind of issue a conditional acceptance should require the authors to address, I do not recommend changing the reader's verdict.","tokens_in":7004,"tokens_out":6113,"duration_ms":64392,"concrete_test":"Re-fit the Section 3.1.1 logistic and Section 3.1.3 Cox models on the HNSCC-MDA cohort with covariates {change in L3 adiposity index, age, sex, stage IVA, baseline L3 adiposity index, baseline L3 skeletal-muscle index}, and re-fit the Section 3.2.2 group model with baseline composition plus age/sex/stage. Report n and event counts for each model. If the change-in-adiposity coefficient remains statistically significant and within roughly 20% of the reported values (0.045 logistic, 0.038 Cox), the concern is resolved; if it attenuates, loses significance, or reverses direction, the central claim as an independent prognostic marker fails.","verdict_should_be":"UNCHANGED","load_bearing_attack":"The central claim rests on the logistic and Cox models in Sections 3.1.1, 3.1.3, and 3.2.2. In all of them the predictor of interest is the change in L3 adiposity index (post-RT minus pre-RT), but the models adjust only for age, sex, and stage IVA (Sections 3.1.1 and 3.1.3) and, in the grouped analysis, for nothing else. Baseline L3 skeletal-muscle index and baseline L3 adiposity index are never included as covariates. This is load-bearing because body-composition change is not independent of baseline composition: patients with low muscle or high fat before radiotherapy have systematically different trajectories of weight and adiposity during treatment, and baseline body composition has known prognostic associations in HNSCC, including in the cited prior study of the same cohort [2]. The coefficient on the change variable could therefore be capturing baseline cachexia, treatment toxicity, or nutritional deterioration rather than an independent effect of adiposity gain. The paper's own Discussion (Section 4) admits that diet, physical activity, and comorbidity data are unavailable, so the abstract's causal-sounding claim about monitoring adiposity is not yet empirically grounded. The absence of any reported sample size or event counts prevents even a rough check of whether the model is overfit or subject to sparse-data bias. This is not an accusation of fabrication; it is a request for the model to be tested against the most obvious alternative explanation.","agreement_with_reader":"partial"},"referee_report":{"model":"deepseek-v4-flash","summary":"This manuscript analyzes the HNSCC-MDA public dataset to examine whether changes in the L3 adiposity index and skeletal muscle status after radiotherapy are associated with recurrence and survival in head and neck squamous cell carcinoma. Using multivariable logistic regression, Cox proportional-hazards models, and Kaplan-Meier analyses, the authors report that an increase in the adiposity index after radiotherapy is significantly associated with higher recurrence and mortality, and that patients with muscle loss and adipose gain have the lowest survival and the highest recurrence risk. The Discussion and Conclusions label the work as preliminary and call for larger confirmatory studies.","tokens_in":7325,"tokens_out":3975,"duration_ms":37596,"significance":"The clinical question is relevant: body-composition changes are potentially modifiable and could inform follow-up in HNSCC. The modeling strategy on a public dataset is transparent, and the regression tables are internally consistent. However, the current manuscript cannot support the abstract's central claim because essential design information is missing and the main analyses omit baseline body-composition covariates. If the authors supply the missing reporting and the association survives adjustment for baseline composition, the finding would be a useful preliminary prognostic signal; as written, the contribution is an unverifiable preliminary analysis.","major_comments":[{"comment":"The Methods state that data come from HNSCC-MDA but do not report the number of patients included, the number of recurrence and death events, inclusion/exclusion criteria, the version of the dataset, or how missing scans or measurements were handled. Without these, the coefficients in Sections 3.1.1, 3.1.3, and 3.2.2 cannot be checked for overfitting or sparse-data bias, and the reader cannot know the analytic sample. This is a load-bearing reporting gap.","section":"Section 2.1"},{"comment":"The logistic and Cox models for adiposity change adjust only for age, sex, and stage IVA. Baseline L3 adiposity index and baseline L3 skeletal-muscle index, both available in the data and both prognostic in prior HNSCC work (ref. [2]), are not included. Since change from baseline is biologically and mathematically correlated with baseline level, the reported coefficient on adiposity change may be capturing baseline nutritional risk or reverse causation rather than an independent effect of adiposity gain. The authors should present models that include baseline composition, or at least a stratified analysis, and should report the correlation between baseline values and change scores.","section":"Sections 3.1.1 and 3.1.3"},{"comment":"The Kaplan-Meier results are described only in words; the text states 'Estas curvas no están disponibles en esta versión preliminar' and 'no mostradas aquí.' No log-rank tests, numbers at risk, or censoring details are given, and the grouping cutpoint for 'significant increase' in adiposity is not defined. The survival claims are therefore not verifiable.","section":"Sections 3.1.2 and 3.2.1"},{"comment":"The four-group Cox model uses only the group indicator, with no covariate adjustment, and the reported hazard ratios may be confounded by age, sex, stage, and baseline body composition. The conclusion that patients with muscle loss and adipose gain have the highest recurrence risk is not robust without adjustment or at least a sensitivity analysis.","section":"Section 3.2.2"},{"comment":"The abstract and introduction promise conclusions about the relative effectiveness of PET/CT, MRI, and CT in follow-up, and the Discussion repeats this. However, no analysis of imaging modality is presented in the Results; Section 2.1 mentions recording imaging type and detection time, but no model or table uses these variables. This unsupported claim should be removed or an actual analysis should be provided.","section":"Abstract and Introduction vs. Results"}],"minor_comments":[{"comment":"There are numerous typographical errors (e.g., 'prelimiar' in Section 4, 'larigne' in the Figure 1 caption) and inconsistent accent usage; the manuscript needs careful proofreading.","section":"Throughout"},{"comment":"The figure is taken from radiopedia.org without a license or attribution beyond the URL; this should be clarified and permission or a proper CC license should be documented.","section":"Figure 1"},{"comment":"The definition of 'estado muscular' and the thresholds used to classify patients into muscle/adipose gain or loss groups are not stated, so the four-group analysis is not reproducible.","section":"Section 2.2.2"},{"comment":"The text should state the statistical software and packages used for the regressions and survival analyses.","section":"Methods"},{"comment":"The Discussion says that sample size and follow-up may be insufficient and that diet, physical activity, and comorbidity data are unavailable, but no actual numbers or quantitative sensitivity checks are provided; these limitations should be connected to specific reported results.","section":"Discussion"}],"recommendation":"major_revision","confidential_remarks":"This is a very preliminary report rather than a complete journal article: no sample size, no data or code, no baseline table, and no Kaplan-Meier curves are provided, and the imaging-modality claim in the abstract is entirely unsupported by the Results. The main scientific concern is that the central association may be confounded by baseline body composition. I would only consider publication after the authors supply the full reporting, add baseline-adjusted analyses, and either remove or substantiate the imaging claims. If the journal does not publish short preliminary reports, this manuscript may be better suited to a preprint server."},"author_rebuttal":null,"desk_editor":{"model":"deepseek-v4-flash","letter":"Quick take: this is a preliminary reanalysis of the public HNSCC-MDA cohort that finds post-RT adiposity gain associates with worse recurrence and survival. The association is plausible and internally consistent, but the manuscript is not yet a complete paper: no sample size, no baseline table, no survival curves, and no imaging analysis despite the abstract promising one.\n\nWhat's actually new: not much. The main result echoes the same group's 2016 JAMA Oncology paper (ref [2], also the dataset source). The four-group muscle/adipose categorization is a mild reformulation, not a new biomarker. The authors do deserve credit for two things: they are upfront that this is preliminary, and they cite the prior study rather than ignoring it.\n\nThe soft spots are real and load-bearing. First, the abstract emphasizes PET/CT, MRI, and CT, but the methods and results sections contain zero imaging analysis. That's a mismatch between claims and content. Second, the core logistic and Cox models adjust only for age, sex, and stage IVA. Baseline L3 muscle and adiposity indices are never included. Since body-composition change is correlated with baseline, the coefficient on change may simply capture baseline cachexia or nutritional risk. The stress-test note is right. Third, there is no reported sample size, event count, or missing-data handling, so we can't even check for sparse-data bias. The paper also omits KM curves and proportional-hazards diagnostics, which the methods imply should be there.\n\nThe citation pattern is fine: they cite Grossberg 2016 and the dataset. No sign of self-citation inflation or invented entities.\n\nBottom line: this reads like a work-in-progress report, not a submittable manuscript. The clinical question is fine, but the value added over ref [2] is small and the reporting gaps are too big. I would not send this to peer review in its current form. I'd desk reject with an invitation to resubmit once the authors state the analytic sample, include baseline composition in the models, and either present the imaging analysis or remove that claim from the abstract. The four-group survival result could be a useful addition if properly framed.","headline":"A preliminary reanalysis of a public HNSCC dataset with a plausible but not novel association, undermined by missing sample definition, omitted baseline confounders, and an imaging claim with no imaging analysis.","tokens_in":7836,"tokens_out":2887,"would_cite":false,"duration_ms":28092,"reading_group":"no","serious_thinker":"yes","would_accept_peer_review":false},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"deepseek-v4-flash","headline":"The paper claims that post-radiotherapy gains in body fat predict higher recurrence and death in head and neck cancer patients.","keywords":["head and neck squamous cell carcinoma","body composition","adiposity index","skeletal muscle loss","radiotherapy","tumor recurrence","survival analysis","PET/CT and MRI follow-up"],"falsifier":"A direct test would be to obtain the full HNSCC-MDA cohort with explicit inclusion and exclusion criteria and missing-data handling, reproduce the L3 measurements, and re-run the same multivariable logistic and Cox regressions; if the adiposity-change coefficient falls to near zero or changes sign when any missing scans are excluded, the central association fails.","tokens_in":6800,"feed_emoji":"📈","tokens_out":5165,"duration_ms":51716,"temperature":0.7,"pith_summary":"The paper sets out to establish that body-composition changes after radiotherapy predict which head and neck squamous cell carcinoma (HNSCC) patients relapse and die. Using the HNSCC-MDA cohort, it reports that an increase in the L3 adiposity index after radiotherapy is significantly associated with higher recurrence and mortality, after adjusting for age, sex, and tumor stage. The combined muscle-and-adipose analysis finds that patients with muscle loss plus adipose gain have the lowest survival probabilities and the highest recurrence risk. The authors explicitly call the work preliminary, so the value of the claim is as a testable prognostic signal rather than a settled clinical rule.","feed_headline":"Fat gain after radiotherapy signals higher head-and-neck cancer risk","feed_subtitle":"Rising L3 adiposity after radiation predicts more recurrences and deaths, especially with muscle loss.","key_machinery":"The central machinery is the change in the L3 adiposity index, measured at the third lumbar vertebra before and after radiotherapy, together with the binary change in skeletal muscle status at the same level. The argument runs through two statistical engines: multivariate logistic regression for recurrence and Cox proportional hazards models for mortality and group-wise recurrence risk. The combined analysis uses a four-group classification of muscle and adipose change, with muscle gain plus adipose loss as the reference group; the hazard coefficients for the remaining groups translate each body-composition trajectory into a recurrence-risk estimate. That set-up is what lets the paper turn routine L3-level measurements into prognostic comparisons.","core_discovery":"The central discovery, stated in the abstract, is that an increase in the adiposity index post-radiotherapy is significantly associated with higher recurrence and mortality rates in HNSCC. In the multivariate logistic regression, the coefficient for change in adiposity index is 0.045 ($p < 0.001$); in the Cox proportional hazards model it is 0.038 ($p < 0.001$), both adjusted for age, sex, and tumor stage. When skeletal muscle and adipose changes are combined into four groups, patients with muscle loss and adipose gain show the lowest survival probabilities and the highest recurrence risk, with a Cox group coefficient of 1.567 ($p < 0.001$) relative to the muscle-gain with adipose-loss reference group. The paper frames itself as a preliminary analysis and calls for larger, longer-term studies to confirm the findings.","pith_inferences":["Editorial inference: the paper's design is associative, so the ordering of adiposity gain and recurrence is untested; a longitudinal analysis of the same cohort could check whether fat gain precedes or follows recurrence.","Editorial inference: imaging modality is discussed but not included as a covariate, so a natural extension is to test whether PET/CT, MRI, or CT follow-up changes the measured association.","Editorial inference: because all results come from one public cohort, an independent replication with explicitly reported inclusion criteria and missing-data handling would be the decisive next validation.","Editorial inference: the clinical payoff, if confirmed, is that body composition becomes an early image-derived warning signal available before recurrence is visible on conventional scans; that would need prospective testing."],"forward_implications":["If the claim is correct, follow-up imaging that already covers the L3 level can flag rising adiposity as a warning sign during post-radiotherapy surveillance.","Patients who lose muscle while gaining fat would be the group most deserving of nutritional or rehabilitative interventions after treatment.","The reported independence from age, sex, and stage IVA suggests body-composition change adds prognostic information beyond standard staging.","Stable or reduced adiposity after radiotherapy would identify a lower-risk trajectory, informing how intensely a patient is monitored.","Body-composition monitoring could be formalized as part of routine response assessment after radiotherapy for HNSCC."],"supporting_citations":[{"why":"supplies the HNSCC-MDA dataset with clinical variables, body-composition measurements, recurrence status, and follow-up imaging used in all analyses.","marker":"[1]"},{"why":"prior study showing body composition is associated with survival and locoregional control in radiotherapy-treated HNSCC, which this analysis extends by focusing on recurrence and imaging follow-up.","marker":"[2]"}],"fun_headline_variants":["Fat gain after radiation flags higher head-and-neck cancer risk","Muscle loss plus fat gain marks worst head-and-neck cancer outlook","Post-radiotherapy adiposity rise predicts head-and-neck cancer relapse","Combined muscle-fat change forecasts head-and-neck cancer survival"],"cache_read_input_tokens":3200,"weakest_assumption_plain":"The load-bearing assumption is that the HNSCC-MDA cohort provides complete, accurately measured L3 muscle and adiposity values before and after radiotherapy, along with reliable recurrence and survival follow-up for a well-defined analytic sample.","fun_headline_variants_meta":{"raw":{"variants":["Fat gain after radiation flags higher head-and-neck cancer risk","Muscle loss plus fat gain marks worst head-and-neck cancer outlook","Post-radiotherapy adiposity rise predicts head-and-neck cancer relapse","Combined muscle-fat change forecasts head-and-neck cancer survival"]},"model":"deepseek-v4-flash","effort":"low","cost_usd":0.000735,"raw_usage":{"total_tokens":3244,"prompt_tokens":864,"completion_tokens":2380,"prompt_tokens_details":{"cached_tokens":384},"prompt_cache_hit_tokens":384,"prompt_cache_miss_tokens":480,"completion_tokens_details":{"reasoning_tokens":2306}},"tokens_in":480,"tokens_out":2380,"duration_ms":149799,"temperature":1.0,"reasoning_tokens":2306,"cache_read_input_tokens":384,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-08-12T13:19:39.806657+00:00","model_set":{"reader":"deepseek-v4-flash"},"falsifier":"A direct test would be to obtain the full HNSCC-MDA cohort with explicit inclusion and exclusion criteria and missing-data handling, reproduce the L3 measurements, and re-run the same multivariable logistic and Cox regressions; if the adiposity-change coefficient falls to near zero or changes sign when any missing scans are excluded, the central association fails.","supporting_citations":[{"cited_title":null,"cited_arxiv_id":null,"evidence_quote":"supplies the HNSCC-MDA dataset with clinical variables, body-composition measurements, recurrence status, and follow-up imaging used in all analyses."},{"cited_title":"J., Chamchod, S., Fuller, C","cited_arxiv_id":null,"evidence_quote":"prior study showing body composition is associated with survival and locoregional control in radiotherapy-treated HNSCC, which this analysis extends by focusing on recurrence and imaging follow-up."}],"review_version":1}